Cure My Disease

Don't miss your cure!

 Log in / Sign up

Quick videos may boost COVID shots in anxious adults

NCT ID NCT06119854

Knowledge-focused Sponsor: City University of New York, School of Public Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested two short digital videos designed to encourage COVID-19 vaccination among 1,419 adults with anxiety or depression who were not up to date on their shots. One video used 'attitudinal inoculation' to build resistance to misinformation, and the other used techniques from cognitive-behavioral therapy (CBT) to address personal barriers. The goal was to see if either approach worked better than standard public health messages in getting people vaccinated within four weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
brief digital videos (attitudinal inoculation and CBT-informed messaging)
What this could lead to
If successful, this could point toward simple, scalable digital tools to boost vaccine confidence in people with anxiety or depression.
What could go wrong
This is a completed study, but the interventions are brief videos, not a medical treatment. Results may not apply to other vaccines or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,419 people

The number who actually took part.

Started

Apr 2024

Finished

Nov 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Recently engaged in the CHASING COVID Cohort study (i.e., started ≥ 1 survey since December 7, 2022) * Last COVID-19 vaccine dose prior to September 11, 2023 * Current residence in the US or a US territory * Comprehension of written English Exclusion Criteria: * No dose of a COVID-19 vaccine * Had a SARS-CoV-2 infection in the past 3 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety anxiety disorder Communication Depression depressive disorder Vaccination Hesitancy COVID-19 prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety COVID-19 Depression Misinformation Vaccine hesitancy

Contacts and locations

Locations

  • CUNY Graduate School of Public Health & Health Policy

    New York, New York, 10027, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.